pentetate (Ca-DTPA, Zn-DPTA)

Tradename: Ca-DTPA, Zn-DTPA (Ca⁺² or Zn⁺² (Na⁺)3 pentetate) (FDA-approved in 2004) Indications: internal contamination from radioactive elements Mechanism of action: - presumptively, chelation with renal clearance Notes: Manufacturer: Hanein

References

Prescriber's Letter 12(2): 2005 New Drugs Approved by the FDA in 2004 Detail-Document#: 210216 (subscription needed) http://www.prescribersletter.com